Details of the Drug

General Information of Drug (ID: DMRK4FA)

Drug Name
N-(2-aminoethyl)-1-aziridine-ethanamine
Synonyms NAAE; N-(2-aminoethyl)-1-aziridineethanamine
Indication
Disease Entry ICD 11 Status REF
Severe acute respiratory syndrome (SARS) 1D65 Investigative [1]
Therapeutic Class
Antiviral Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 129.199
Logarithm of the Partition Coefficient (xlogp) -1.3
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C6H15N3
IUPAC Name
N'-[2-(aziridin-1-yl)ethyl]ethane-1,2-diamine
Canonical SMILES
C1CN1CCNCCN
InChI
InChI=1S/C6H15N3/c7-1-2-8-3-4-9-5-6-9/h8H,1-7H2
InChIKey
XJNAQZHMIAKQOK-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
98888
ChEBI ID
CHEMBL398940
CAS Number
23435-23-6
UNII
K93WMR7E2S
DrugBank ID
DB15643
TTD ID
D05JBC
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HUMAN angiotensin-converting enzyme 2 (ACE2) TTYRG7F ACE2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.